Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018081

See Plans and Pricing

« Back to Dashboard

NDA 018081 describes DEPAKENE, which is a drug marketed by Abbvie and is included in two NDAs. It is available from one supplier. Additional details are available on the DEPAKENE profile page.

The generic ingredient in DEPAKENE is valproic acid. There are seventeen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.
Summary for 018081
Ingredient:valproic acid
Formulation / Manufacturing:see details
Pharmacology for NDA: 018081
Medical Subject Heading (MeSH) Categories for 018081
Suppliers and Packaging for NDA: 018081
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEPAKENE valproic acid CAPSULE;ORAL 018081 NDA REMEDYREPACK INC. 70518-1459 70518-1459-0 30 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (70518-1459-0)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.